Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Efficacy of liquid biopsy for disease monitoring and early prediction of tumor progression in EGFR mutation-positive non-small cell lung cancer.
Journal: PloS one
Published: December 08, 2021
Budget Impact Analysis of EGFR Mutation Liquid Biopsy for First- and Second-Line Treatment of Metastatic Non-Small Cell Lung Cancer in Greece.
Journal: Diagnostics (Basel, Switzerland)
Published: June 04, 2020
Clinical utility of a blood-based EGFR mutation test in patients receiving first-line erlotinib therapy in the ENSURE, FASTACT-2, and ASPIRATION studies.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: June 07, 2018
Detection of EGFR Variants in Plasma: A Multilaboratory Comparison of a Real-Time PCR EGFR Mutation Test in Europe.
Journal: The Journal of molecular diagnostics : JMD
Published: October 16, 2017
The Clinical and Economic Impact of Inaccurate EGFR Mutation Tests in the Treatment of Metastatic Non-Small Cell Lung Cancer.
Journal: Journal of personalized medicine
Published: April 04, 2017
A phase 1b study of trebananib in combination with pegylated liposomal doxorubicin or topotecan in women with recurrent platinum-resistant or partially platinum-sensitive ovarian cancer.
Journal: Gynecologic oncology
Published: April 23, 2014
Showing 1-7 of 7
Last Updated: 09/26/2026